S49 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Supernus Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 41.8 EUR 0.48%

Market Cap: €2.3B

S	Supernus Pharmaceuticals Inc SWB:S49	US
	Tuya Inc F:7850	CN
	Barclays PLC LSE:BARC	UK
S	Semirara Mining and Power Corporation XPHS:SCC	PH
	Lintec Corp F:57T	JP
U	UDR Inc F:UF0	US
	General de Alquiler de Maquinaria SA F:4LX	ES
G	Geron Corp F:GON	US
B	Berkshire Hathaway Inc DUS:BRYN	US
S	Supernus Pharmaceuticals Inc F:S49	US
A	Amcor PLC XMUN:485	UK
	Triboo SpA F:0T6	IT
U	Unilever PLC F:UNVA	UK
C	Centene Corp F:QEN	US
	Peach Property Group AG SIX:PEAN	CH
	M3 Inc OTC:MTHRY	JP
	Coveo Solutions Inc F:I94	CA
P	Pfizer Inc XBER:PFE	US
P	Perion Network Ltd F:IW2	IL
S	Schumag AG XHAM:SCM	DE
M	Mattel Inc XMUN:MTT	US
P	Public Service Enterprise Group Inc SWB:PSE	US
C	Coterra Energy Inc DUS:XCQ	US
P	Prudential Financial Inc DUS:PLL	US

Profitability Summary

Supernus Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

90%

Strong 3Y Average Gross Margin

88%

Gross Margin is Increasing

86% > 90%

Negative Operating Margin

-8%

Low 3Y Average Operating Margin

Declining Operating Margin

7% > -8%

Negative Net Margin

-4%

Low 3Y Average Net Margin

Declining Net Margin

8% > -4%

Exceptional Free Cash Flow Margin

11%

Strong 3Y Average Free Cash Flow Margin

18%

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.